Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool’s free investing community, generic-drug giant Teva Pharmaceutical Industries (Nasdaq: TEVA  ) has earned a coveted five-star ranking. With that in mind, let’s take a closer look at Teva’s business and see what CAPS investors are saying about the stock right now. [...]